ClinicalTrials.gg
Active, not recruitingNCT07156474Updated Aug 6, 2026

Impact of Intraoperative Blood Pressure Components on Postoperative AKI: A Phenotype-Stratified Analysis

An observational study in Postoperative Acute Kidney Injury and Intraoperative Hypotension, sponsored by Lanyue Zhu. Active, not recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Lanyue Zhu · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
44,504
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 168 studies in Acute Kidney Injury with a site in China — 46 open to participants now, 54 under way, 1 of them phase 3. Acute Kidney Injury · China.

Planned enrollment
6th of 105
44,504 · median 472
Started
2025
with 9 others
Observational
105 of 168
26 open now
Primary completion
2026-12
later than 21 of 53 live
Registered
139th of 168
by date

Among the 168 studies in Acute Kidney Injury with a site in China, this one is the 6th largest by planned enrollment of the 105 observational ones that give a count, is one of 10 that started in 2025, is one of 105 observational ones, reaches primary completion later than 21 of the 53 other live ones, and was the 139th registered.

Acute Kidney Injury

1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.

Browse Acute Kidney Injury studies →

Open to participants now

46 of the 168 studies in Acute Kidney Injury with a site in China are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Acute Kidney Injury with a site in China, or all of them as a file.
02

Study summary

Postoperative acute kidney injury (AKI) is a serious complication often linked to low blood pressure during surgery. This study aims to better protect patients' kidneys by personalizing how blood pressure is managed during an operation.

The project has two main goals:

First, researchers will analyze data from over 44,000 past surgeries to identify which specific blood pressure measurements are the most critical warning signs for kidney damage.

Second, using this knowledge, they will build a smart tool (a machine learning model) to predict a unique, safe blood pressure target for each individual patient before their surgery begins.

This personalized approach is intended to give doctors a specific target to maintain during surgery, helping to prevent kidney injury and improve patient safety.

Read the detailed description
  1. Study Rationale Postoperative Acute Kidney Injury (AKI) is a common and severe complication following non-cardiac surgery, leading to prolonged hospital stays, increased medical costs, and a higher risk of persistent kidney failure or death. Intraoperative hypotension (abnormally low blood pressure during surgery) is recognized as a significant contributor to AKI, as it can reduce blood flow and oxygen supply to the kidneys.

    Currently, there is no clinical consensus on which component of blood pressure-such as systolic (SBP), diastolic (DBP), or mean arterial pressure (MAP)-is the most critical to monitor for preventing organ injury. Furthermore, current guidelines often recommend a universal "one-size-fits-all" threshold for hypotension (e.g., MAP \< 65 mmHg). This approach fails to account for individual patient differences, such as baseline blood pressure and co-existing health conditions, which may mean that the optimal blood pressure target varies significantly from person to person.

    This study aims to address these gaps by using a large, multi-center dataset to first identify the most critical blood pressure components linked to AKI and then to develop a tool that predicts a personalized, optimal blood pressure threshold for individual patients.

  2. Study Objectives

This study is divided into two parts:

Part 1: Risk Assessment and Blood Pressure Component Analysis

  1. Primary Objective: To evaluate the association between different intraoperative blood pressure components (SBP, DBP, MAP) and the incidence of postoperative AKI in distinct patient subgroups, which will be identified by clustering patients based on their preoperative baseline characteristics.
  2. Secondary Objective: To assess the association between these blood pressure components and the incidence of postoperative Acute Kidney Disease (AKD), a condition of longer-duration kidney damage.

Part 2: Development of a Personalized Prediction Model

  1. Primary Objective: To develop and validate a dynamic machine learning model that provides an individualized prediction of the optimal intraoperative hypotension threshold for patients undergoing non-cardiac surgery.
  2. Secondary Objectives:

    • To build a machine learning model that predicts a patient's risk of developing postoperative AKI based on their preoperative data.

      ②To explore the relationship between the cumulative 5-minute lowest intraoperative blood pressure and postoperative AKI, using this relationship to refine the predictive model.

      3. Study Design and Methods This is a retrospective, multi-center cohort study.

    • Data Sources: The study will utilize de-identified electronic health record data from several large sources: the public INSPIRE database, Zhongda Hospital affiliated with Southeast University (2013-2024), Nanjing First Hospital (2016-2024), and the First Affiliated Hospital of Anhui Medical University (2013-2023).

      • Study Population: The study will include adult patients (age ≥ 18) who underwent non-cardiac surgery and had available intraoperative blood pressure monitoring data. An initial dataset of approximately 850,000 surgical records will be screened, with an estimated final cohort of 44,504 eligible patients after applying inclusion and exclusion criteria. Key exclusions include patients with pre-existing severe chronic kidney disease, those undergoing urological or kidney-related surgeries, and procedures with a short duration of anesthesia (\<60 min).

        • Analysis Plan:

In Part 1, the research team will use unsupervised clustering methods (e.g., K-means) to group patients based on preoperative characteristics. Subsequently, multivariable logistic regression models will be used to analyze the association between intraoperative hypotension metrics and the risk of postoperative AKI/AKD within the overall cohort and across the different patient clusters.

In Part 2, machine learning algorithms, including XGBoost and Random Forest, will be employed to develop a series of predictive models. The final model will be designed to dynamically adjust a patient's hypotension threshold by iteratively calculating the AKI risk until it falls below a predefined safety level (10%). The model's performance will be rigorously evaluated using metrics such as the Area Under the Curve (AUC), and its interpretability will be assessed using SHAP (Shapley Additive Explanations) analysis.

03

Conditions studied

  • Postoperative Acute Kidney Injury
  • Intraoperative Hypotension
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All non-cardiac surgery data from INSPIRE database and all non-cardiac surgery data from 2013-2024 in Zhongda Hospital Southeast University, 2016-2024 in Nanjing First Hospital and 2013-2023 in Anhui Medical University Affiliated First Hospital were selected.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients undergoing non-cardiac surgery
  2. Access to intraoperatively available invasive/noninvasive blood pressure monitoring data

Exclusion criteria

Exclusion Criteria:

  1. Patients for Age \< 18 yr
  2. Patients without preoperative or postoperative creatinine records
  3. Patients undergoing urinary surgeries
  4. Patients with chronic kidney injury before surgery
  5. > 5 class
  6. Anesthesia duration \< 60 min
  7. Patients for non-available lowest blood pressure data during surgery
  8. Hemodynamic records loss more than 25% of the total anesthesia duration
  9. Patients for categorical variables records missing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
44,504 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Postoperative AKI

    KDIGO criteria for diagnosis (≥0.3 mg/dL or ≥1.5-fold increase in creatinine value)

    Time frame: Within 7 days post-op

  2. Individualized Optimal Intraoperative Hypotension Threshold.

    A patient-specific blood pressure threshold predicted by a dynamic machine learning model. This threshold is identified as the blood pressure value at which the model-predicted risk of postoperative Acute Kidney Injury (AKI) falls below 10%.

    Time frame: preoperative period

Secondary outcomes

  1. Postoperative AKD

    KDIGO criteria for diagnosis (≥0.3 mg/dL or ≥1.5-fold increase in creatinine value)

    Time frame: Within 8-90 days post-op

  2. length of hospital stay

    the interval from the end of surgery to discharge

    Time frame: Through hospital discharge, an average of 1 weak

  3. Predicted Risk of Postoperative AKI.

    The probability of developing postoperative AKI, as calculated by a machine learning model using preoperative baseline data. Measured by AUROC, AUPRC and Calibration Curve

    Time frame: preoperative period

  4. Predicted Lowest Intraoperative Blood Pressure.

    The predicted cumulative 5-minute lowest intraoperative blood pressure value, generated by a machine learning model based on preoperative data. Measured by R2 and MAE

    Time frame: preoperative period

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2025
First posted
Sep 5, 2025
StartActual
Sep 9, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07156474
Lead sponsor
Lanyue Zhu
Responsible party
Lanyue Zhu (Attending Physician, Zhongda Hospital) — Sponsor-investigator
First posted
Sep 5, 2025
Start date
Sep 9, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 6, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion